HomeOSE • EPA
add
Ose Immunotherapeutics SA
Previous close
€6.70
Day range
€6.65 - €6.84
Year range
€3.12 - €11.58
Market cap
144.81M EUR
Avg Volume
130.28K
P/E ratio
2.95
Dividend yield
-
Primary exchange
EPA
Market news
Investing.com
1 day ago
Stock market today: S&P 500 closes higher on cooling inflation, rally in
banks
1.83%
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 41.29M | 5,980.49% |
Operating expense | 9.63M | 29.53% |
Net income | 28.59M | 582.08% |
Net profit margin | 69.24 | 107.93% |
Earnings per share | — | — |
EBITDA | 31.72M | 620.54% |
Effective tax rate | 5.83% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 75.75M | 404.37% |
Total assets | 140.92M | 75.30% |
Total liabilities | 59.47M | 2.79% |
Total equity | 81.45M | — |
Shares outstanding | 21.76M | — |
Price to book | 1.79 | — |
Return on assets | 56.17% | — |
Return on capital | 63.15% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 28.59M | 582.08% |
Cash from operations | 33.20M | 666.23% |
Cash from investing | -27.46M | -50,021.82% |
Cash from financing | -2.15M | -523.35% |
Net change in cash | 3.59M | 167.77% |
Free cash flow | 20.60M | 818.87% |
About
Founded
Nov 17, 2004
Website
Employees
52
